Review



gabazine hydrobromide  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Tocris gabazine hydrobromide
    Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of <t>gabazine</t> (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.
    Gabazine Hydrobromide, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 580 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/95531+hydrobromide/bio_rxiv__64898__2026__04__16__718853-91-7-9?v=Tocris
    Average 96 stars, based on 580 article reviews
    gabazine hydrobromide - by Bioz Stars, 2026-07
    96/100 stars

    Images

    1) Product Images from "P2X7 receptor-mediated astrocytic atrophy in the hippocampus of mice after status epilepticus"

    Article Title: P2X7 receptor-mediated astrocytic atrophy in the hippocampus of mice after status epilepticus

    Journal: bioRxiv

    doi: 10.64898/2026.04.16.718853

    Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of gabazine (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.
    Figure Legend Snippet: Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of gabazine (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.

    Techniques Used:



    Similar Products

    96
    Tocris gabazine hydrobromide
    Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of <t>gabazine</t> (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.
    Gabazine Hydrobromide, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/95531+hydrobromide/bio_rxiv__64898__2026__04__16__718853-91-7-9?v=Tocris
    Average 96 stars, based on 1 article reviews
    gabazine hydrobromide - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Tocris sr95531
    Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of <t>gabazine</t> (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.
    Sr95531, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/95531+hydrobromide/pmc12995702-9-0-2?v=Tocris
    Average 96 stars, based on 1 article reviews
    sr95531 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Tocris 95531 hydrobromide
    Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of <t>gabazine</t> (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.
    95531 Hydrobromide, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/95531+hydrobromide/us12589114-313-5-7?v=Tocris
    Average 96 stars, based on 1 article reviews
    95531 hydrobromide - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Tocris gabazine
    Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of <t>gabazine</t> (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.
    Gabazine, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/95531+hydrobromide/pmc12925530-32-0-2?v=Tocris
    Average 96 stars, based on 1 article reviews
    gabazine - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Tocris sr95531 hydrobromide
    Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of <t>gabazine</t> (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.
    Sr95531 Hydrobromide, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/95531+hydrobromide/pmc12925530-335-10-17?v=Tocris
    Average 96 stars, based on 1 article reviews
    sr95531 hydrobromide - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Tocris 95531 hydrobromide gabazine
    Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of <t>gabazine</t> (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.
    95531 Hydrobromide Gabazine, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/95531+hydrobromide/pm41839847-213-20-28?v=Tocris
    Average 96 stars, based on 1 article reviews
    95531 hydrobromide gabazine - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Tocris gabazine sr 95531 hydrobromide tocris bioscience
    Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of <t>gabazine</t> (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.
    Gabazine Sr 95531 Hydrobromide Tocris Bioscience, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/95531+hydrobromide/pm41719120-761-68-72?v=Tocris
    Average 96 stars, based on 1 article reviews
    gabazine sr 95531 hydrobromide tocris bioscience - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of gabazine (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.

    Journal: bioRxiv

    Article Title: P2X7 receptor-mediated astrocytic atrophy in the hippocampus of mice after status epilepticus

    doi: 10.64898/2026.04.16.718853

    Figure Lengend Snippet: Spontaneous postsynaptic currents (sPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) of hippocampal CA1 pyramidal neurons; effects of Bz-ATP. sEPSCs were recorded in the continuous presence of gabazine (10 µM). Bz-ATP (300 µM) effects on the amplitude and frequency of the spontaneous currents in low X 2+ aCSF. (A) Representative recordings or sPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (B) Representative, averaged sPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (C) Mean±S.E.M. sPSC amplitudes (left panel) and mean±S.E.M. frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (D) Percentage changes of sPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test), as calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells. (E) Representative recordings or sEPSCs before, during, and after superfusion with Bz-ATP for 5 min, as well as after washing out this agonist. (F) Representative, averaged sEPSC amplitude before, during and after a 5 min superfusion with Bz-ATP. (G) Mean±S.E.M. sEPSC amplitudes (left panel) and mean±S.E.M. sEPSC frequencies (right panel) calculated from 11 cells. P>0.05 all; one-way ANOVA, followed by the Tukey’s test in both panels. (H) Percentage changes of sEPSC amplitudes (left panel; P>0.05 all, Kruskal-Wallis ANOVA, followed by the Dunn’s test) and frequency (right panel; P>0.05 all; one-way ANOVA, followed by the Tukey’s test; §§ P<0.01; Kruskal-Wallis ANOVA, followed by the Dunn’s test) were calculated relative to the pre-Bz-ATP amplitude and frequency set at 100%, and shown as mean±S.E.M. values of 11 cells.

    Article Snippet: The drugs used were the following: JNJ-47965567, gabazine hydrobromide (Tocris Biosciences, Bristol, UK); kainic acid hydrate (MedChem Express, Monmouth Junction, NJ, USA); diazepam (Shanghai Xudong Haipu Pharmaceutical Co., Shanghai, China).

    Techniques: